Lifecore biomedical reports fourth quarter and full fiscal year 2023 results

Chaska, minn., aug. 31, 2023 (globe newswire) -- lifecore biomedical, inc. (nasdaq: lfcr) (“lifecore” or the “company”), a fully integrated contract development and manufacturing organization (“cdmo”), reported results for the fiscal 2023 fourth quarter and full year ended may 28, 2023.
LFCR Ratings Summary
LFCR Quant Ranking